Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology

BACKGROUND: Xihuang Pill (XHP) is mainly used to treat “Ru Yan (breast cancer)”. Evidence-based medical evidence and showed that XHP improves the efficacy of chemotherapy and reduced chemotherapy-induced toxicity in breast cancer patients. However, the mechanism of XHP against breast cancer is not c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kailin, Zeng, Liuting, Ge, Anqi, Bao, Tingting, Xu, Tao, Xie, Xiaobing, Liu, Lifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300251/
https://www.ncbi.nlm.nih.gov/pubmed/32595497
http://dx.doi.org/10.3389/fphar.2020.00825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300251/
https://www.ncbi.nlm.nih.gov/pubmed/32595497
http://dx.doi.org/10.3389/fphar.2020.00825

Ejemplares similares